Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention
Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 57-64
Open Access | Times Cited: 10

Showing 10 citing articles:

Pharmacological management of migraine: current strategies and future directions
Lanfranco Pellesi, Thien Phu, Anders Hougaard
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 673-683
Open Access | Times Cited: 8
Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success
Lanfranco Pellesi, Lars Edvinsson
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Targeting PACAP: Beyond Migraine to Cluster, Menstrual, and Post-traumatic Headaches
Lanfranco Pellesi, Mona Ameri Chalmer, Song Guo, et al.
Advances in Therapy (2025)
Open Access
PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study
Elisabeth Storch, Lucas Hendrik Overeem, Maria Terhart, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Single-centre, randomised and double-blind clinical trial on the efficacy of transcutaneous auricular vagus nerve stimulation in preventing and treating primary headache in children and adolescents: a study protocol
Siqi Weng, Xue-Zhen Xiao, Siqi Liang, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e092692-e092692
Open Access
From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment
Artur Galushkin, Illana Gozes
Current Research in Biotechnology (2024) Vol. 8, pp. 100254-100254
Open Access | Times Cited: 3
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review
Abimael González‐Hernández, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2024)
Closed Access | Times Cited: 2
A New Antibody Treatment for Migraine
Elizabeth Loder
New England Journal of Medicine (2024) Vol. 391, Iss. 9, pp. 855-857
Closed Access
Injectable Gel-PEG hydrogels as promising delivery system for intravitreal PACAP release: Novel therapeutics for unilateral common carotid artery occlusion induced retinal ischemia
Moxin Chen, XiaoYi Liang, XiRui Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117427-117427
Open Access
The prodrome of migraine: mechanistic insights and emerging therapeutic strategies
Liang Gao, Fangling Zhao, Yujie Tu, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Page 1

Scroll to top